Inhibitor Therapeutics, Inc.
INTI· OTC
INTIInhibitor Therapeutics, Inc.
Filed Mar 26, 2021 · 10-K · 85 days after period end · 0001193125-21-095516
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | $0.00 |
| Net Income | -$55.85K | -$635.83K | -$1.33M | -$904.22K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inhibitor Therapeutics, Inc. · CIK 1042418 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 26, 2021 · 85 d after period end
